Heparin in the treatment of cerebral venous thrombosis

Saad Shafqat, Ayeesha K. Kamal, Mohammad Wasay

Research output: Contribution to journalReview articlepeer-review

6 Citations (Scopus)


Cerebral venous thrombosis (CVT) is a potentially life-threatening condition requiring rapid diagnosis and urgent treatment. Heparin anticoagulation is the time-honoured treatment, and is advocated in all cases of CVT, irrespective of etiology or presence of haemorrhage. The supportive evidence is largely observational; data from randomized placebo-controlled trials shows a nonsignificant trend favouring heparin. Current practice is to begin heparin (unfractionated or low-molecular weight) immediately on confirmation of the diagnosis. Newer antithrombotic agents such as ximelagatran may offer advantages over heparin and need to be investigated in the treatment of CVT.

Original languageEnglish
Pages (from-to)541-543
Number of pages3
JournalJournal of the Pakistan Medical Association
Issue number11
Publication statusPublished - Nov 2006


Dive into the research topics of 'Heparin in the treatment of cerebral venous thrombosis'. Together they form a unique fingerprint.

Cite this